Novolog Pharm-Up 1966 Ltd. announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was ILS 1,133.643 million compared to ILS 1,004.138 million a year ago. Operating income was ILS 61.092 million compared to ILS 33.060 million a year ago. Net income was ILS 40.067 million compared to ILS 10.137 million a year ago. Basic earnings per share from continuing operations was ILS 0.086 compared to ILS 0.026 a year ago. Diluted earnings per share from continuing operations was ILS 0.085 compared to ILS 0.026 a year ago.